Weighing benefits and risks of drug to treat obesity.
Sukkari
S R
SR
D001067:Appetite Depressants / Q000009:adverse effects* / Q000627:therapeutic use; D016265:Conflict of Interest; D005277:Fenfluramine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D009765:Obesity / Q000188:drug therapy*; D018570:Risk Assessment
D001067:Appetite Depressants; D005277:Fenfluramine